Astellas, Amgen To Pay $125M To End Kickback Probe
Law360 (April 25, 2019, 1:21 PM EDT) -- Astellas Pharma US Inc. and Amgen Inc. will pay a combined $125 million to settle allegations that they used charities to subsidize Medicare co-pays for their own drugs in what amounted to illegal kickbacks, the U.S. Attorney's Office for the District of Massachusetts announced Thursday.
Astellas Pharma US and Amgen will cough up $100 million and $24.75 million, respectively, to settle claims that they paid illegal kickbacks through co-pay assistance foundations. (Getty)
The pharmaceutical companies are the seventh and eighth companies to resolve similar allegations in Massachusetts related to kickbacks to third-party foundations, known as patient co-pay assistance foundations, bringing the total...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!